NeueHealth Inc.

NYSE: NEUE · Real-Time Price · USD
6.36
-0.36 (-5.39%)
At close: Aug 15, 2025, 12:22 PM

NeueHealth Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
209.08M 215.79M 232.64M 232.93M 225.99M 245.09M 292.87M 269.4M 297.98M 756.34M 551.42M 1.63B 1.58B 1.84B 962.33M 1.08B 1.11B 874.56M
Cost of Revenue
146.41M 160.89M 184.89M 182.69M 177.68M 196.87M 264.86M 226.44M 245.16M 688.51M n/a n/a -1.43B n/a n/a n/a n/a n/a
Gross Profit
62.67M 54.89M 47.75M 50.24M 48.31M 48.22M 28.01M 42.96M 52.82M 67.83M 551.42M 1.63B 3B 1.84B 962.33M 1.08B 1.11B 874.56M
Operating Income
14.26M 2.66M -29.42M -17.34M -37.55M -23.1M -45.94M -462.77M -23.41M -85.75M -71.39M -53.31M -68.73M -96.82M 35.23M -296.28M -59.05M -22.83M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 948K n/a n/a n/a
Pretax Income
6.82M -1.33M -43.15M -23.21M -39.45M 6.35M -61.24M -482.69M -32.58M -93.53M -192.46M -257.6M -248.43M -177.39M -821.67M -296.65M -63.19M -23.38M
Net Income
-23.5M -11.74M -2.72M -57.41M -58.63M -15.91M -229.72M -633.89M -112.83M -175.01M -679.57M -306.07M -274.67M -195.23M -814.52M -300.66M -44.52M -25.16M
Selling & General & Admin
n/a n/a 84.83M 60.32M 66.2M 62.34M 56.51M 66.2M 64.58M 129.21M 93.09M 85.58M 79M 96.79M 252.34M 309.79M 261.06M 208.24M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
194.82M 213.13M -7.67M 7.26M -74.21M -71.38M -51.11M -99.07M -74.95M -150.22M -163.26M -387.57M -386.49M -431.22M -370.9M -313.59M -267.27M n/a
Operating Expenses
194.82M 213.13M 77.16M 67.58M 74.21M 71.38M 73.82M 99.07M 74.95M 150.22M 163.26M 387.57M 386.49M 431.22M 370.9M 313.59M 267.27M 897.39M
Interest Expense
6.88M 6.64M 6.25M 5.41M 4.11M 2.93M 11.21M 10.04M 9.17M 7.79M 6.39M 4.91M 337K 1.19M 1.67M 1.59M 4.14M 546K
Selling & Marketing Expenses
n/a n/a -384K 174K 210K n/a -1.46M 258K 630K 20.34M -167.12M 313K n/a n/a n/a n/a n/a n/a
Cost & Expenses
341.24M 374.02M 262.06M 250.28M -251.89M -268.25M 338.68M 325.51M 320.11M 838.73M -715.42M -1.77B -1.82B -2.01B -1.79B -1.36B -1.17B 897.39M
Income Tax Expense
-21K 111K -672K 2.79M -187K 663K 1.59M -3.38M -892K 1.26M -4.23M 1.76M 2.9M 3.24M -8.3M 73K -19.46M 1.17M
Shares Outstanding (Basic)
8.75M 8.57M 8.23M 8.28M 8.25M 8.08M 7.95M 7.98M 7.96M 7.89M 7.88M 7.87M 7.87M 7.86M 7.86M 7.85M 7.82M 1.75M
Shares Outstanding (Diluted)
8.75M 8.57M 8.23M 8.28M 8.25M 8.08M 7.95M 7.98M 7.96M 7.89M 7.88M 7.87M 7.87M 7.86M 7.86M 7.85M 7.82M 1.75M
EPS (Basic)
-2.63 -2.9 -1.94 -8.51 -7.1 -1.97 -28.88 -79.47 -14.17 -22.17 -86.26 -38.88 -34.92 -24.84 -103.66 -38.29 -5.69 -14.36
EPS (Diluted)
-2.63 -2.9 -1.94 -8.51 -7.1 -1.97 -28.88 -79.47 -14.17 -22.17 -86.26 -38.88 -34.92 -24.84 -103.66 -38.29 -5.69 -14.36
EBITDA
-13.09M 8.87M -33.3M -14.3M -31.36M 13.84M -46.01M -468.53M -18.74M -25.53M 65.92M -103.91M -35.93M -163.94M -810.49M -282.08M -51.85M -18.25M
EBIT
n/a 5.31M -36.9M -17.8M -35.34M 9.28M -50.03M -472.65M -23.41M -44.87M 55.51M -95.92M -71.52M -159.08M -820M -295.06M -59.05M -22.83M
Depreciation & Amortization
3.56M 3.56M 3.6M 3.5M 3.98M 4.56M 4.03M 4.12M 4.67M 9.89M 10.4M 13.9M 13.23M 13.04M 9.5M 14.21M 7.2M 22.83M